Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Gemcitabine in BCG-Refractory NMIBC
NCT00234039Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Nov 2006
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in bladder cancer, sponsored by SWOG Cancer Research Network. Started Nov 2006; status: completed.
02
Drugs
gemcitabine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00234039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234039.